EZH2 and depressive symptom measurement: To verify the role of EZH2 in depression rats, EZH2 levels in the hippocampus of CUMS-treated rats were successfully reduced (p < 0.01, Figure 2(a)) through the injection of sh-EZH2 into the hippocampus (Figure 2(b,c)).